155 related articles for article (PubMed ID: 947938)
1. Prolactin and testosterone: independent circulating levels in hyperprolactinemic and normoprolactinemic amenorrhea. The effect of prolactin suppression by bromocriptine.
Seppälä M; Hirvonen E; Unnérus HA; Ranta T; Laatikainen T
J Clin Endocrinol Metab; 1976 Jul; 43(1):198-200. PubMed ID: 947938
[TBL] [Abstract][Full Text] [Related]
2. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Hirvonen E; Ranta T; Seppäla M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
Seppälä M; Unnérus HA; Hirvonen E; Ranta T
J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical function in hyperprolactinemic women.
Carter JN; Tyson JE; Warne GL; McNeilly AS; Faiman C; Friesen HG
J Clin Endocrinol Metab; 1977 Nov; 45(5):973-80. PubMed ID: 200633
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
[TBL] [Abstract][Full Text] [Related]
7. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
Fukunaga T
Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
[TBL] [Abstract][Full Text] [Related]
8. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
Prelević GM; Würzburger MI; Perić LA
J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
[TBL] [Abstract][Full Text] [Related]
10. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
Nillius SJ
Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
[TBL] [Abstract][Full Text] [Related]
12. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
[TBL] [Abstract][Full Text] [Related]
13. Prolactin response to thyrotropin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy.
Steinberger E; Nader S; Rodriguez-Rigau L; Ayala C; Smith K
J Endocrinol Invest; 1990 Sep; 13(8):637-42. PubMed ID: 2148756
[TBL] [Abstract][Full Text] [Related]
14. Serum prolactin levels in postpill amenorrheic patients.
Karaman AS; Uran B; Erler A
Int J Gynaecol Obstet; 1993 Nov; 43(2):177-80. PubMed ID: 7905434
[TBL] [Abstract][Full Text] [Related]
15. [A study on the significance of bromocriptine (CB-154) administration in normoprolactinemic anovulatory women (author's transl)].
Ishimaru T; Mori H; Koh K; Imamichi S; Morisaki M; Kohno A; Yoshida K; Imamura S; Yamabe T
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1583-90. PubMed ID: 7240824
[TBL] [Abstract][Full Text] [Related]
16. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
[TBL] [Abstract][Full Text] [Related]
17. Failure of bromocriptine to restore the menstrual cycle in normoprolactinemic post-pill amenorrhea.
Coelingh Bennink HJ; van der Steeg HJ
Fertil Steril; 1983 Feb; 39(2):238-40. PubMed ID: 6822306
[TBL] [Abstract][Full Text] [Related]
18. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
19. Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats.
McComb DJ; Hellmann P; Thorner MO; Scott D; Evans WS; Kovacs K
Am J Pathol; 1986 Jan; 122(1):7-16. PubMed ID: 3942200
[TBL] [Abstract][Full Text] [Related]
20. A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic admknistration of bromocriptine.
Thorner MO; Schran HF; Evans WS; Rogol AD; Morris JL; MacLeod RM
J Clin Endocrinol Metab; 1980 Jun; 50(6):1026-33. PubMed ID: 7189523
[No Abstract] [Full Text] [Related]
[Next] [New Search]
